A case of Brucella spondylitis in a patient with psoriatic arthritis receiving infliximab (Journal article)
Papagoras, C. E./ Argyropoulou, M. I./ Voulgari, P. V./ Vrabie, I./ Zikou, A. K./ Drosos, A. A.
A 69-year-old woman with psoriatic arthritis treated with infliximab presented with low back pain of recent onset and fever. Serological, microbiological and imaging studies revealed Brucella spondylitis at the L5-S1 level. Immunosuppressive therapy was suspended and antibiotic therapy including doxycycline and rifampicin was administered for six months. The patient responded adequately with clinical and laboratory improvement and a considerable remission of spondylitis on repeat magnetic resonance imaging scan. The pathophysiology of tumor necrosis factor (TNF) alpha in Brucellosis and the role of anti-TNFalpha therapy are discussed.
|Institution and School/Department of submitter:||Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής|
|Keywords:||Aged,Anti-Bacterial Agents/therapeutic use,Antibodies, Monoclonal/*adverse effects,Arthritis, Psoriatic/*drug therapy,Brucellosis/diagnosis/drug therapy/*immunology,Doxycycline/therapeutic use,Drug Therapy, Combination,Female,Humans,Immunity, Innate/immunology,Rifampin/therapeutic use,Spondylitis/*microbiology,Tumor Necrosis Factor-alpha/*antagonists & inhibitors/immunology|
|Appears in Collections:||Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)|
Files in This Item:
There are no files associated with this item.
Please use this identifier to cite or link to this item:This item is a favorite for 0 people.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.